Ilooda Co., Ltd announced that it expects to receive KRW 10 billion in funding
November 25, 2021
Share
Ilooda Co., Ltd announced that it will issue series 3 Unregistered coupon nonguaranteed private convertible bond for gross proceeds of KRW 10,000,000,000 on November 26, 2021. The bonds will be issued at par. The transaction will include participation from BNK Securities Co., Ltd. for KRW 2,500,000,000, Platinum-Innovative Venture Fund for KRW 3,000,000,000, Orion KOSDAQ Venture Hedge Fund 40 for KRW 200,000,000, Orion Growth-Multi KOSDAQ Venture Hedge Fund 42 for KRW 300,000,000, Orion Luxury KOSDAQ Venture Hedge Fund 49 for KRW 200,000,000, Orion Mezzanine KOSDAQ Venture General Private Equity Trust 64 for KRW 300,000,000, GVA Coven-V General Private Equity Trust for KRW 1,000,000,000, GVA Coven-i General Private Equity Trust (Professional Investor) for KRW 1,000,000,000, Fides Luna KOSDAQ Venture Hedge Fund for KRW 1,000,000,000, and Cape KOSDAQ Venture Specialized Private Equity Trust for KRW 500,000,000. The bonds will bear a zero coupon rate of and an interest to maturity rate of 0%. The bonds will mature on November 30, 2026. The bonds are convertible into 902,934 common shares at a fixed conversion price of KRW 11,075 share from November 30, 2022 to October 30, 2026. The date of subscription is November 30, 2021and expected date of payment is November 30, 2021. The transaction is approved by the board of directors of the company.
Ilooda Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of medical devices. The Company's main products include medical devices for skin care, medical devices for pigmentation and blood vessels, home and personal beauty devices, dental medical devices, ophthalmic medical devices, and other medical devices. The Company sells its products in domestic and overseas markets.
ILOODA CO., LTD 
